The central pressor response to bradykinin is localized to the ventral third ventricle, similar to angiotensin II.
Answers are grounded in this paper and cite their sources.
Animal data offer no clinical guidance for hypertension; leaves open third ventricular bradykinin localization in humans.
Bradykinin injected into the lateral ventricle produces a rise in blood pressure. Cream plugs selectively localized to discrete regions of the ventricular system were used to block drug access to periventricular sites. Third ventricular plugs blocked the pressor response to lateral ventricular injections of 5 micrograms bradykinin (27 +/- 5 before vs. 5 +/- 5 mmHg after plug, n = 7) and 100 ng angiotensin II (22 +/- 3 before vs. 4 +/- 2 mmHg after plug, n = 5). Third ventricular plugs also suppressed the drinking response to angiotensin II (3.7 +/- 0.6 before vs. 0.9 +/- 0.6 ml after plug, n = 5). However, plugs that occluded the fourth ventricle failed to suppress the central bradykinin pressor response (27 +/- 8 before vs. 35 +/- 9 mmHg after plug, n = 5). The data suggest that the central bradykinin pressor response has a site of action similar to that of angiotensin II in the ventral third ventricle.
No takes yet. Share an insight, caveat, or question.
Lewis et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: